Effects of three serotonin reuptake inhibitors on sign-tracking in male Sprague-Dawley rats

Physiol Behav. 2023 Sep 1:268:114233. doi: 10.1016/j.physbeh.2023.114233. Epub 2023 May 10.

Abstract

Sign-tracking is a behavior with relevance to cue-triggered relapse addiction, a Pavlovian conditioned approach behavior directed at the conditioned stimulus. The study examined one strategy for reducing the magnetic pull of drug-associated conditioned stimuli, using selective serotonin reuptake inhibitors (SSRIs) citalopram (0, 10, and 20 mg/kg), escitalopram (0, 10, and 20 mg/kg) and fluoxetine (0, 5, and 10 mg/kg). Male Sprague-Dawley rats were first trained in a standard sign-tracking task and then acutely administered these drugs in a series of three experiments. In each study, it was found that measures of sign-tracking were reduced, although effects on goal-tracking were different between drugs. This study provides evidence that administration of serotonergic antidepressants is effective in reducing sign-tracking and may have some efficacy in preventing cue-triggered relapse.

Keywords: Addiction; Citalopram; Escitalopram; Fluoxetine; Serotonin; Sign-tracking.

MeSH terms

  • Animals
  • Antidepressive Agents* / pharmacology
  • Citalopram / pharmacology
  • Fluoxetine / pharmacology
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Selective Serotonin Reuptake Inhibitors* / pharmacology

Substances

  • Selective Serotonin Reuptake Inhibitors
  • Antidepressive Agents
  • Citalopram
  • Fluoxetine